Respiro Diagnostics

Raised £1.0M

Stage

Pre-seed

Amount raised

£1.0M

Lead investor

Zinc Venture Capital

Co-investors

SFC Capital

Sectors

healthtechbiotech

Detected

9 July 2026

Confidence

95%

Source

Respiro Diagnostics, a UK-based startup developing non-invasive breath-based diagnostics for lung diseases, raised £1 million in pre-seed funding led by Zinc Venture Capital and SFC Capital. The technology uses exhaled breath… https://t.co/NllM0IQuTr #Funding #1M5M #Healthtech

9 Jul 2026

For founders

Get matched to investors deploying now.

Get matched →